Exploring ways to understand and treat Alzheimer's disease through aging research
Using geroscience to understand and treat Alzheimer's disease
This study is looking at how aging affects Alzheimer's disease to find new treatments, and it might give patients a chance to try out some promising drugs that could help with their condition and possibly improve their overall health.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Salk Institute for Biological Studies NIH-funded |
| Lab location | 1 site (La Jolla, UNITED STATES) |
| Project ID | NIH-10874410 on NIH RePORTER |
What this research studies
This research investigates the relationship between aging and Alzheimer's disease to identify potential treatments. By repurposing existing drugs and employing a lifespan approach, the study aims to validate drug targets that remain effective in older individuals. The research utilizes a unique screening platform to discover compounds that may not only treat Alzheimer's but also extend lifespan, with some already in clinical trials. Patients may have the opportunity to participate in trials for these promising new therapies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals aged 65 and older who are experiencing symptoms of Alzheimer's disease or related dementias.
Not a fit: Patients under the age of 65 or those without any cognitive impairment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to effective treatments for Alzheimer's disease, improving the quality of life for patients and their families.
How similar studies have performed: Previous research has shown promise in using lifespan approaches to identify potential treatments for neurodegenerative diseases, indicating that this approach may yield significant results.
Where this research is happening
La Jolla, UNITED STATES
- Salk Institute for Biological Studies — La Jolla, United States (Active)
Researchers
- Principal investigator: Maher, Pamela Anne — Salk Institute for Biological Studies
- Study coordinator: Maher, Pamela Anne
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.